Method and composition for angiogenesis inhibition

Details for Australian Patent Application No. 2005215017 (hide)

Owner Cancervax Corporation

Inventors Broek, Daniel; Freimark, Bruce; Brooks, Peter

Agent Griffith Hack

Pub. Number AU-A-2005215017

PCT Pub. Number WO2005/079508

Priority 60/545,376 17.02.04 US

Filing date 17 February 2005

Wipo publication date 1 September 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/079508 Priority application(s): WO2005/079508

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215018-Interactive multimedia smart affinity card

2005215013-Managing wheel slip and skid in a locomotive